• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多西他赛治疗血清前列腺特异抗原水平低而癌胚抗原水平高的复发性前列腺癌:一例报告

[Recrudescent prostate cancer with a low serum PSA level and a high serum CEA level treated with docetaxel : a case report].

作者信息

Fujita Masahiro, Goto Takayasu, Uchida Kinya, Saiki Shigeru, Arima Ryoichi

机构信息

The Department of Urology, Federation of National Public Service and Affiliated Personnel Mutual Aid Association Otemae Hospital.

出版信息

Hinyokika Kiyo. 2013 Mar;59(3):183-8.

PMID:23633635
Abstract

A 63-year-old man was hospitalized with an increased serum prostate specific antigen (PSA) level (72 ng/ml). A prostate biopsy was performed, and histological examinations indicated moderately and poorly differentiated adenocarcinoma with positive staining for carcinoembryonic antigen (CEA). The patient was diagnosed as having prostate cancer (clinical stage : T3bN0M0) and received radiotherapy and hormonal therapy. Five years after the diagnosis, the serum CEA level increased to 153.8 ng/dl, and the patient complained of abdominal pain. His serum PSA level remained normal (<0.1 ng/dl). Computed topography indicated multiple bone metastasis and the involvement of multiple lymph glands. A biopsy of a cervical lymph gland revealed poorly differentiated adenocarcinoma with positive staining for CEA. Gastrointestinal examination showed no evidence of abnormality. The diagnosis of metastatic prostate cancer was made, and docetaxel (60-70 mg/m2) was administered. Eight courses of docetaxel therapy led to an approximately 20% reduction in lymph volume, and the serum CEA level decreased. However, liver metastases developed 12 months later, and the patient died at 18 months after the diagnosis of metastatic prostate cancer with a high serum CEA level. We encountered a case of recrudescence of prostate cancer positive for CEA with a low serum PSA level and report the effect of docetaxel therapy for atypical prostatic carcinoma.

摘要

一名63岁男性因血清前列腺特异性抗原(PSA)水平升高(72 ng/ml)入院。进行了前列腺活检,组织学检查显示为中低分化腺癌,癌胚抗原(CEA)染色呈阳性。该患者被诊断为前列腺癌(临床分期:T3bN0M0),并接受了放疗和激素治疗。诊断后五年,血清CEA水平升至153.8 ng/dl,患者主诉腹痛。其血清PSA水平仍正常(<0.1 ng/dl)。计算机断层扫描显示多处骨转移及多个淋巴结受累。颈部淋巴结活检显示为低分化腺癌,CEA染色呈阳性。胃肠道检查未发现异常。诊断为转移性前列腺癌,给予多西他赛(60 - 70 mg/m²)治疗。八个疗程的多西他赛治疗使淋巴结体积减少了约20%,血清CEA水平下降。然而,12个月后出现肝转移,患者在诊断为转移性前列腺癌且血清CEA水平高18个月后死亡。我们遇到了一例血清PSA水平低但CEA阳性的前列腺癌复发病例,并报告了多西他赛治疗非典型前列腺癌的效果。

相似文献

1
[Recrudescent prostate cancer with a low serum PSA level and a high serum CEA level treated with docetaxel : a case report].多西他赛治疗血清前列腺特异抗原水平低而癌胚抗原水平高的复发性前列腺癌:一例报告
Hinyokika Kiyo. 2013 Mar;59(3):183-8.
2
[Recrudescence of prostate cancer with low serum level of PSA and high serum level of CEA and CA19-9: a case report].[血清前列腺特异抗原(PSA)水平低而癌胚抗原(CEA)和糖类抗原19-9(CA19-9)水平高的前列腺癌复发:一例报告]
Hinyokika Kiyo. 2007 Jul;53(7):485-7.
3
Relapsed prostate cancer with neuroendocrine differentiation and high serum levels of carcinoembryonic antigen without elevation of prostrate-specific antigen: a case report.伴有神经内分泌分化且癌胚抗原血清水平高而前列腺特异性抗原未升高的复发性前列腺癌:一例报告
Int J Urol. 2007 Feb;14(2):147-9. doi: 10.1111/j.1442-2042.2007.01616.x.
4
[Prostate cancer with high serum level of CEA and CA19-9: a case report].[血清癌胚抗原和糖类抗原19-9水平升高的前列腺癌:一例报告]
Hinyokika Kiyo. 1998 Mar;44(3):187-91.
5
M1 prostate cancer with a serum level of prostate-specific antigen less than 10 ng/mL.
Int J Urol. 2001 Jul;8(7):374-9. doi: 10.1046/j.1442-2042.2001.00316.x.
6
A case of metastatic cancer with markedly elevated PSA level that was not detected by repeat prostate biopsy.一例转移性癌症患者,其前列腺特异性抗原(PSA)水平显著升高,但经重复前列腺活检未检测到。
BMC Res Notes. 2014 Jan 29;7:64. doi: 10.1186/1756-0500-7-64.
7
[Neuroendocrine differentiation in adenocarcinoma of the prostate during hormonal treatment : a case report].[激素治疗期间前列腺腺癌中的神经内分泌分化:一例报告]
Hinyokika Kiyo. 2010 Jan;56(1):49-54.
8
Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancer.多西他赛、贝伐单抗与雄激素剥夺疗法用于前列腺癌确定性局部治疗后生化复发疾病的治疗
Cancer. 2015 Aug 1;121(15):2603-11. doi: 10.1002/cncr.29398. Epub 2015 Apr 22.
9
Weekly docetaxel/estramustine phosphate in patients with increasing serum prostate- specific antigen levels after primary treatment for prostate cancer: a phase II trial of the Minnie Pearl Cancer Research Network.多西他赛/磷酸雌莫司汀每周给药方案用于前列腺癌初次治疗后血清前列腺特异性抗原水平升高患者:米妮·珀尔癌症研究网络的II期试验
Clin Genitourin Cancer. 2006 Mar;4(4):287-92. doi: 10.3816/CGC.2006.n.009.
10
[Prostate cancer of unknown primary origin with multiple lymph nodes metastasis; a case report].[原发灶不明伴多发淋巴结转移的前列腺癌;1例病例报告]
Nihon Hinyokika Gakkai Zasshi. 2014 Oct;105(4):212-7. doi: 10.5980/jpnjurol.105.212.